<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>43(1)</volume><submitter>Luo W</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Macrophages play important roles in phagocytosing tumor cells. However, tumors escape macrophage phagocytosis in part through the expression of anti-phagocytic signals, most commonly CD47. In Ewing sarcoma (ES), we found that tumor cells utilize dual mechanisms to evade macrophage clearance by simultaneously over-expressing CD47 and down-regulating cell surface calreticulin (csCRT), the pro-phagocytic signal. Here, we investigate the combination of a CD47 blockade (magrolimab, MAG) to inhibit the anti-phagocytic signal and a chemotherapy regimen (doxorubicin, DOX) to enhance the pro-phagocytic signal to induce macrophage phagocytosis of ES cells in vitro and inhibit tumor growth and metastasis in vivo.&lt;h4>Methods&lt;/h4>Macrophages were derived from human peripheral blood m</pubmed_abstract><journal>Journal of experimental &amp; clinical cancer research : CR</journal><pagination>193</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11238356</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning "Two Keys" simultaneously.</pubmed_title><pmcid>PMC11238356</pmcid><pubmed_authors>Liao Y</pubmed_authors><pubmed_authors>Rosenblum JM</pubmed_authors><pubmed_authors>Costello H</pubmed_authors><pubmed_authors>Wijeratne S</pubmed_authors><pubmed_authors>Cassady KA</pubmed_authors><pubmed_authors>Zhu H</pubmed_authors><pubmed_authors>Hoang H</pubmed_authors><pubmed_authors>Cairo MS</pubmed_authors><pubmed_authors>Ayello J</pubmed_authors><pubmed_authors>Miller KE</pubmed_authors><pubmed_authors>Chemnitz W</pubmed_authors><pubmed_authors>Mardis ER</pubmed_authors><pubmed_authors>Gandhi R</pubmed_authors><pubmed_authors>Cripe TP</pubmed_authors><pubmed_authors>Luo W</pubmed_authors><pubmed_authors>Xu S</pubmed_authors><pubmed_authors>Gardenswartz A</pubmed_authors><pubmed_authors>Lee DA</pubmed_authors><pubmed_authors>Mo X</pubmed_authors><pubmed_authors>Garfinkle EAR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning "Two Keys" simultaneously.</name><description>&lt;h4>Background&lt;/h4>Macrophages play important roles in phagocytosing tumor cells. However, tumors escape macrophage phagocytosis in part through the expression of anti-phagocytic signals, most commonly CD47. In Ewing sarcoma (ES), we found that tumor cells utilize dual mechanisms to evade macrophage clearance by simultaneously over-expressing CD47 and down-regulating cell surface calreticulin (csCRT), the pro-phagocytic signal. Here, we investigate the combination of a CD47 blockade (magrolimab, MAG) to inhibit the anti-phagocytic signal and a chemotherapy regimen (doxorubicin, DOX) to enhance the pro-phagocytic signal to induce macrophage phagocytosis of ES cells in vitro and inhibit tumor growth and metastasis in vivo.&lt;h4>Methods&lt;/h4>Macrophages were derived from human peripheral blood m</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-06-01T13:31:38.639Z</modification><creation>2026-04-08T13:10:42.91Z</creation></dates><accession>S-EPMC11238356</accession><cross_references><pubmed>38992659</pubmed><doi>10.1186/s13046-024-03093-w</doi></cross_references></HashMap>